Evidence map›Paper›PMID 38845956›Full record

ArticleHeliyon2024

A multi-period optimal distribution model of emergency resources for responding to COVID-19 under uncertain conditions.

Yanyan Wang

Abstract read
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Yanyan WangFaculty of Humanities and Social Sciences, Harbin Institute of Technology, Harbin, 150001, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ideally, optimal emergency resource allocation would have been vital for effective relief work during the COVID-19 outbreak. However, the suddenness of the epidemic and uncertainty of its spread added some difficulties to distributing emergency resources. First, this study introduces triangular fuzzy numbers to describe the uncertainty of supply and demand of emergency resources, and interval numbers to describe the time required for resource transportation under disaster conditions. To minimize the total delivery time and difference in the total satisfaction rate, this study constructs an optimal model for emergency resource distribution under uncertain conditions that considers both efficiency and equity. Subsequently, an improved genetic algorithm (IMGA) is proposed to obtain the optimal decision scheme. Finally, a case study on emergency resource distribution during the COVID-19 pandemic is conducted for model verification. The results demonstrate that the proposed model can improve the efficiency and effect of emergency resource distribution. The model allocates some emergency resources to each demand site during each emergency period, which can help avoid large losses caused by extreme shortages of resources at a certain demand point. The emergency resource allocation scheme considers the transportation time and degree of impact, which is beneficial for enhancing the flexibility of decision-making and practical applicability of distribution operations. A comparative analysis of the algorithms shows that the proposed IMGA is an effective method for managing emergency resource distribution optimization problems because it has higher solving efficiency, better convergence, and stronger stability. These findings can provide decision support for the optimal distribution of large-scale, multiperiod emergency resources during the COVID-19 pandemic.

Indexed as

COVID-19Emergency resource distributionIMGA algorithmUncertain conditions

Identifiers

PMID38845956
PMCPMC11153173

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.